A detailed history of True Wealth Design, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, True Wealth Design, LLC holds 613 shares of CTKB stock, worth $3,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares
613
Previous 817 24.97%
Holding current value
$3,371
Previous $2.84 Million 9.21%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026

SELL
$3.61 - $5.5 $736 - $1,122
-204 Reduced 24.97%
613 $3.1 Million
Q3 2025

Oct 21, 2025

SELL
$3.1 - $4.17 $99 - $133
-32 Reduced 3.77%
817 $2.84 Million
Q2 2025

Aug 06, 2025

SELL
$2.42 - $3.99 $759 - $1,252
-314 Reduced 27.0%
849 $2.89 Million
Q1 2025

May 13, 2025

BUY
$4.0 - $7.26 $4,652 - $8,443
1,163 New
1,163 $4.66 Million

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $740M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.